SCHEMBL13601550

SCHEMBL13601550

CN(C)C(=O)COC(=O)C1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
MAPT P10636 2/20 0.44
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
TSHR P16473 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39
PMP22 Q01453 1/20 0.39
GABRA6 Q16445 1/20 0.39
GABRG1 Q8N1C3 1/20 0.39
GABRG3 Q99928 1/20 0.39
GABRQ Q9UN88 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28677940 0.90 KDM4E (0.42) KDM4EMAPTGABRPGABRDGABRA1
SCHEMBL25845608 0.80 GABRP (0.43) MAPTGABRPGABRDGABRA1TSHR
Ethyl Isonipecotate SCHEMBL6439825 0.80 MAPT (0.51) MAPTGABRPGABRDGABRA1TSHR
Ethyl Isonipecotate SCHEMBL27886 0.80 MAPT (0.51) MAPTGABRPGABRDGABRA1TSHR
Ethyl Isonipecotate SCHEMBL1420351 0.78 MAPT (0.50) MAPTGABRPGABRDGABRA1TSHR
SCHEMBL18625010 0.78 GABRA5 (0.50) MAPTGABRPGABRDGABRA1TSHR
SCHEMBL13601795 0.78 MAPT (0.54) KDM4EMAPTALDH1A1
SCHEMBL28598650 0.77 GABRP (0.41) MAPTGABRPGABRDGABRA1TSHR
SCHEMBL9654364 0.77 PLG (0.46) KDM4EMAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL9654358 0.77 PLG (0.46) KDM4EMAPTALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed